F. Rivière

2.6k total citations
49 papers, 221 citations indexed

About

F. Rivière is a scholar working on Pulmonary and Respiratory Medicine, Epidemiology and Oncology. According to data from OpenAlex, F. Rivière has authored 49 papers receiving a total of 221 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Pulmonary and Respiratory Medicine, 14 papers in Epidemiology and 8 papers in Oncology. Recurrent topics in F. Rivière's work include Lung Cancer Diagnosis and Treatment (6 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (5 papers) and Lung Cancer Treatments and Mutations (5 papers). F. Rivière is often cited by papers focused on Lung Cancer Diagnosis and Treatment (6 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (5 papers) and Lung Cancer Treatments and Mutations (5 papers). F. Rivière collaborates with scholars based in France, United States and Canada. F. Rivière's co-authors include J. Margery, Olivier Bylicki, C. Chouaïd, Régis Peffault de Latour, Anne Bergeron, Sylvie Chevret, Morgane Didier, Karine Chagnon, Constance de Margerie‐Mellon and Marie Robin and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Infectious Diseases and Clinical Cancer Research.

In The Last Decade

F. Rivière

41 papers receiving 213 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
F. Rivière France 7 100 53 52 52 49 49 221
John D. Geil United States 7 137 1.4× 24 0.5× 42 0.8× 84 1.6× 86 1.8× 7 309
Fábio Luiz Coracin Brazil 10 102 1.0× 21 0.4× 33 0.6× 24 0.5× 69 1.4× 30 262
Rachel Clack United Kingdom 6 54 0.5× 101 1.9× 19 0.4× 36 0.7× 90 1.8× 13 242
Élodie Merieau France 8 59 0.6× 33 0.6× 34 0.7× 41 0.8× 10 0.2× 20 220
Godfrey Clark United Kingdom 9 29 0.3× 40 0.8× 52 1.0× 45 0.9× 17 0.3× 20 267
Ashish Sharma India 11 50 0.5× 90 1.7× 121 2.3× 87 1.7× 26 0.5× 70 366
Goetz Wehl Austria 7 31 0.3× 30 0.6× 47 0.9× 76 1.5× 70 1.4× 12 249
Omar Touhami Tunisia 10 43 0.4× 53 1.0× 54 1.0× 115 2.2× 27 0.6× 28 437
Michele Lloid United States 9 243 2.4× 79 1.5× 30 0.6× 49 0.9× 177 3.6× 13 501
G Tydén Sweden 9 33 0.3× 50 0.9× 116 2.2× 89 1.7× 52 1.1× 24 296

Countries citing papers authored by F. Rivière

Since Specialization
Citations

This map shows the geographic impact of F. Rivière's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Rivière with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Rivière more than expected).

Fields of papers citing papers by F. Rivière

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F. Rivière. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Rivière. The network helps show where F. Rivière may publish in the future.

Co-authorship network of co-authors of F. Rivière

This figure shows the co-authorship network connecting the top 25 collaborators of F. Rivière. A scholar is included among the top collaborators of F. Rivière based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F. Rivière. F. Rivière is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Rivière, F., et al.. (2023). Infection with Influenzavirus A in a murine model induces epithelial bronchial lesions and distinct waves of innate immune-cell recruitment. Frontiers in Immunology. 14. 1241323–1241323. 3 indexed citations
2.
Rivière, F., et al.. (2022). Single-centre experience of transbronchial cryobiopsy as a first choice method for the diagnosis of interstitial lung disease. Indian Journal of Thoracic and Cardiovascular Surgery. 38(2). 142–148. 1 indexed citations
3.
Bondeelle, Louise, Maud Salmona, Jérôme LeGoff, et al.. (2021). Evaluation of prognostic scores for respiratory syncytial virus infection in a French multicentre cohort of allogeneic haematopoietic stem cell transplantation recipients. Bone Marrow Transplantation. 56(12). 3032–3041. 11 indexed citations
4.
Buob, David, et al.. (2021). Renal Involvement in Eosinophilic Granulomatosis With Polyangiitis. Kidney International Reports. 6(10). 2718–2721. 6 indexed citations
5.
Bylicki, Olivier, F. Rivière, Florence Canouï‐Poitrine, et al.. (2020). Factors Associated With Aggressiveness of End-of-Life Care for Lung Cancer Patients and Associated Costs of Care. Clinical Lung Cancer. 22(3). e320–e328. 10 indexed citations
6.
Eberst, Guillaume, Amélie Anota, Arnaud Scherpereel, et al.. (2019). Health-Related Quality of Life Impact from Adding Bevacizumab to Cisplatin-Pemetrexed in Malignant Pleural Mesothelioma in the MAPS IFCT-GFPC-0701 Phase III Trial. Clinical Cancer Research. 25(19). 5759–5765. 15 indexed citations
7.
Floch, H. Le, et al.. (2019). Evaluation of pneumococcal urinary antigen testing for respiratory tract infection investigations. Médecine et Maladies Infectieuses. 50(1). 57–62. 3 indexed citations
8.
Bylicki, Olivier, et al.. (2019). Lung cancer and end-of-life care: a systematic review and thematic synthesis of aggressive inpatient care. BMJ Supportive & Palliative Care. 9(4). 413–424. 35 indexed citations
9.
Ficko, C., et al.. (2017). Nocardiose disséminée à Nocardia nova avec abcès cérébraux et ostéomyélite chez un patient immunocompétent. La Revue de Médecine Interne. 39(1). 57–61. 1 indexed citations
10.
Margery, J., et al.. (2016). Coma hypoglycémique et co-trimoxazole chez un patient non diabétique. Médecine et Maladies Infectieuses. 46(4). 236–237. 2 indexed citations
11.
Breton, David Le, et al.. (2013). Résultats et enseignements d’une stratégie innovante de prise en charge des nausées et vomissements chimio-induits. Bulletin du Cancer. 100(9). 799–810. 2 indexed citations
12.
Margery, J., Pierre Ruffiè, F. Rivière, et al.. (2011). Second-line therapy in patients with malignant pleural mesothelioma. French retrospective study 2005-2006. European Respiratory Journal. 38(Suppl 55). 2951–2951. 2 indexed citations
13.
Rivière, F., et al.. (2011). Hairy trachea!!. European Journal of Cardio-Thoracic Surgery. 40(2). 530–530. 1 indexed citations
14.
Margery, J., F. Rivière, David Planchard, et al.. (2010). Traitement de seconde ligne dans le mésothéliome pleural malin. Étude rétrospective française (2005–2006). Revue de Pneumologie Clinique. 66(4). 255–259. 6 indexed citations
15.
Rivière, F., H. Le Floch, J. Margery, et al.. (2010). Cancer bronchique bifocal : une même histologie ?. Revue de Pneumologie Clinique. 67(2). 113–117. 1 indexed citations
16.
Méchaï, F., F. Rivière, Audrey Mérens, et al.. (2010). Caractéristiques clinicobiologiques des méningites à Enterovirus de l’adulte : étude de 59 cas. La Revue de Médecine Interne. 31(9). 596–599. 8 indexed citations
17.
Rivière, F., et al.. (2010). Treatment of recurrent respiratory papillomatosis lung involvement by cidofovir infusion. Scandinavian Journal of Infectious Diseases. 43(2). 112–114. 2 indexed citations
18.
Margery, J., H. Le Floch, F. Rivière, et al.. (2010). Place du pneumologue dans la prise en charge d’un traumatisé du thorax. Revue de Pneumologie Clinique. 66(4). 239–244. 1 indexed citations
19.
Floch, H. Le, et al.. (2007). Une péricardite atypique. Revue des Maladies Respiratoires. 24(9). 1147–1150. 2 indexed citations
20.
Bègué, P, et al.. (1990). Otites moyennes aiguës de l'enfant: étude clinique randomisée et ouverte de l'efficacité de deux antibiotiques majeurs (ethylsuccinate d'erythromycine/acétyl-sulfafurazole versus amoxicillin/acid clavulanique)]. 37(2). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by John D. Geil Breakdown of academic impact, for papers by Fábio Luiz Coracin Breakdown of academic impact, for papers by Rachel Clack Breakdown of academic impact, for papers by Élodie Merieau Breakdown of academic impact, for papers by Godfrey Clark Breakdown of academic impact, for papers by Ashish Sharma Breakdown of academic impact, for papers by Goetz Wehl Breakdown of academic impact, for papers by Omar Touhami Breakdown of academic impact, for papers by Michele Lloid Breakdown of academic impact, for papers by G Tydén
Rankless by CCL
2026